|国家科技期刊平台
| 注册
首页|期刊导航|国际肝胆胰疾病杂志(英文版)|AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway

AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway

Qing-Qi Zhang Qian Chen Pan Cao Chun-Xia Shi Lu-Yi Zhang Lu-Wen Wang Zuo-Jiong Gong

国际肝胆胰疾病杂志(英文版)2024，Vol.23Issue(1)：43-51,9.
✕
国际肝胆胰疾病杂志(英文版)2024，Vol.23Issue(1)：43-51,9.DOI:10.1016/j.hbpd.2023.03.003

AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway

AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway

Qing-Qi Zhang 1Qian Chen 1Pan Cao 1Chun-Xia Shi 1Lu-Yi Zhang 1Lu-Wen Wang 1Zuo-Jiong Gong1

作者信息

  • 1. Department of Infectious Diseases,Renmain Hospital of Wuhan University,Wuhan 430060,China
  • 折叠

摘要

关键词

SIRT2 inhibitor/AGK2/Acute liver failure/MFN2/Ferroptosis

Key words

SIRT2 inhibitor/AGK2/Acute liver failure/MFN2/Ferroptosis

引用本文复制引用

Qing-Qi Zhang,Qian Chen,Pan Cao,Chun-Xia Shi,Lu-Yi Zhang,Lu-Wen Wang,Zuo-Jiong Gong..AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway[J].国际肝胆胰疾病杂志(英文版),2024,23(1):43-51,9.

基金项目

This study was supported by the grant from the National Natu-ral Science Foundation of China(82070609). （82070609）

国际肝胆胰疾病杂志(英文版)

1499-3872

访问量0
|
下载量0
段落导航相关论文